Type 2 Diabetes, Hypoglycemia, and Basal Insulins: Ongoing Challenges

被引：11

作者：

Blumer, Ian ^{[1
,2
]}

Clement, Maureen ^{[3
]}

机构：

[1] Charles H Best Diabet Ctr, Ajax, ON, Canada

[2] Univ Toronto, Dept Med, Toronto, ON, Canada

[3] Univ British Columbia, Diabet Educ Ctr, Vernon, BC, Canada

来源：

CLINICAL THERAPEUTICS | 2017年 / 39卷 / 08期

关键词：

basal insulin; hypoglycemia; management; type; 2; diabetes; TO-TARGET TRIAL; PATIENT-REPORTED OUTCOMES; GLARGINE; 100; UNITS/ML; GLYCEMIC CONTROL; COGNITIVE FUNCTION; GLUCOSE CONTROL; NPH INSULIN; PEOPLE; DEGLUDEC; RISK;

D O I：

10.1016/j.clinthera.2016.09.020

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Hypoglycemia in people with insulin-treated type 2 diabetes can be a limiting factor for management and a barrier to optimizing glycemic control. Even mild episodes of hypoglycemia can affect an individual's quality of life, and fear of hypoglycemia can lead to underinsulinization. This article explores the prevalence and consequences of hypoglycemia in people with type 2 diabetes with a focus on those who use basal insulins, offering strategies for prevention and management. It also discusses the benefits and challenges associated with new basal insulins, and their potential role in reducing hypoglycemia risk. (C) 2017 Elsevier HS Journals, Inc. All rights reserved.

引用

页码：S1 / S11

页数：11

共 50 条

[41] Impact of Insulin Glargine on Glycemic Control and Hypoglycemia in Patients With Type 1 Diabetes Previously Treated With Other Insulins
Chase, Peter
Lin, Jay
Wei, Wenhui
Cali, Anna
Dailey, George
DIABETES, 2013, 62 : A650 - A650
[42] HYPOGLYCEMIA RISK ASSOCIATED WITH BASAL INSULIN USE IN TYPE 2 DIABETES (T2DM): THE LIGHTNING STUDY
Meneghini, L.
Zhou, F. L.
Bosnyak, Z.
Berria, R.
Jimenez, J.
Bailey, T.
DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A45 - A46
[43] Inhaled and Background Basal Insulins Improved A1C and QoL Subdomains in Patients with Type 2 Diabetes: An Observational Study
Kipnes, Mark
Salhin, Amna
Ryan, Terri
Vadakekalam, Jacob
Pamar, Vijayveer
Trigoso, Fernando
Akhrass, Firas
DIABETES, 2020, 69
[44] Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins
Arutchelvam, V.
Heise, T.
Dellweg, S.
Elbroend, B.
Minns, I.
Home, P. D.
DIABETIC MEDICINE, 2009, 26 (10) : 1027 - 1032
[45] Potential Predictors of Hypoglycemia in Type 1 and Type 2 Diabetes
Kotwal, Anupam
English, Thomas
Malkani, Samir
DIABETES, 2015, 64 : A102 - A102
[46] Ongoing Challenges with Type 2 Myocardial Infarction Reply
Sarkisian, Laura
Saaby, Lotte
Thygesen, Kristian
Mickley, Hans
AMERICAN JOURNAL OF MEDICINE, 2016, 129 (08): : E157 - E157
[47] Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors
Zhang, Tingting
Ji, Linong
Gao, Yan
Zhang, Puhong
Zhu, Dongshan
Zhang, Heng
Li, Xian
Ji, Jiachao
Guo, Xiaohui
DIABETES, 2017, 66 : A618 - A618
[48] Observational registry of basal insulin treatment (ORBIT) in patients with type 2 diabetes in China: safety and hypoglycemia predictors
Zhang, Tingting
Ji, Linong
Gao, Yan
Zhang, Puhong
Zhu, Dongshan
Li, Xian
Ji, Jiachao
Zhao, Fang
Zhang, Heng
Guo, Xiaohui
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33
[49] The Association of Hypoglycemia Severity and Economic Outcomes among Patients with Type 2 Diabetes Mellitus Using Basal Insulin
Lee, Lulu
Wang, Hongwei
Tong, Liyue
Gupta, Shaloo
Preblick, Ronald
Meneghini, Luigi F.
DIABETES, 2016, 65 : A102 - A102
[50] Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis
Hoogwerf, Byron J.
Lincoff, A. Michael
Rodriguez, Angel
Chen, Lei
Qu, Yongming
CARDIOVASCULAR DIABETOLOGY, 2016, 15

← 1 2 3 4 5 →